Epithelial-mesenchymal transition-related genes are linked to aggressive local recurrence of hepatocellular carcinoma after radiofrequency ablation.

[1]  Baocun Sun,et al.  Hypoxia promotes vasculogenic mimicry formation by the Twist1-Bmi1 connection in hepatocellular carcinoma. , 2015, International journal of molecular medicine.

[2]  Meiyan Wu,et al.  HIF-1α Promotes Epithelial-Mesenchymal Transition and Metastasis through Direct Regulation of ZEB1 in Colorectal Cancer , 2015, PloS one.

[3]  Pallavi Sontakke,et al.  Hypoxia enhances migration and invasion in glioblastoma by promoting a mesenchymal shift mediated by the HIF1α-ZEB1 axis. , 2015, Cancer letters.

[4]  T. Utsunomiya,et al.  Expressions of Hypoxia-Inducible Factor-1 and Epithelial Cell Adhesion Molecule are Linked with Aggressive Local Recurrence of Hepatocellular Carcinoma After Radiofrequency Ablation Therapy , 2014, Annals of Surgical Oncology.

[5]  M. Ziol,et al.  ESM-1 expression in stromal cells is predictive of recurrence after radiofrequency ablation in early hepatocellular carcinoma. , 2013, Journal of hepatology.

[6]  D. Schuppan,et al.  Sublethal heat treatment promotes epithelial‐mesenchymal transition and enhances the malignant potential of hepatocellular carcinoma , 2013, Hepatology.

[7]  Lemin Zheng,et al.  Insufficient radiofrequency ablation promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells through Akt and ERK signaling pathways , 2013, Journal of Translational Medicine.

[8]  Jiyeon Kim,et al.  CK2 Inhibitor CX-4945 Blocks TGF-β1-Induced Epithelial-to-Mesenchymal Transition in A549 Human Lung Adenocarcinoma Cells , 2013, PloS one.

[9]  M. Waltham,et al.  Treatment with the vascular disruptive agent OXi4503 induces an immediate and widespread epithelial to mesenchymal transition in the surviving tumor , 2013, Cancer medicine.

[10]  Osamu Matsui,et al.  Comparison of resection and ablation for hepatocellular carcinoma: a cohort study based on a Japanese nationwide survey. , 2013, Journal of hepatology.

[11]  M. Gazouli,et al.  Expression of microRNAs, miR‐21, miR‐31, miR‐122, miR‐145, miR‐146a, miR‐200c, miR‐221, miR‐222, and miR‐223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its prognostic significance , 2013, Molecular carcinogenesis.

[12]  H. Baba,et al.  High CD44s expression is associated with the EMT expression profile and intrahepatic dissemination of hepatocellular carcinoma after local ablation therapy , 2013, Journal of hepato-biliary-pancreatic sciences.

[13]  Y. Toiyama,et al.  MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis , 2012, Gut.

[14]  Bing Pan,et al.  Insufficient Radiofrequency Ablation Promotes Angiogenesis of Residual Hepatocellular Carcinoma via HIF-1α/VEGFA , 2012, PloS one.

[15]  Hanmin Wang,et al.  Hypoxia-Induced Down-Regulation of microRNA-34a Promotes EMT by Targeting the Notch Signaling Pathway in Tubular Epithelial Cells , 2012, PloS one.

[16]  M. Sogayar,et al.  Epithelial-mesenchymal transition: implications in cancer progression and metastasis. , 2011, Current pharmaceutical biotechnology.

[17]  R. Agami,et al.  MicroRNA regulation by RNA-binding proteins and its implications for cancer , 2011, Nature Reviews Cancer.

[18]  C. Dai,et al.  Mechanism of the Mesenchymal–Epithelial Transition and Its Relationship with Metastatic Tumor Formation , 2011, Molecular Cancer Research.

[19]  J. Bruix,et al.  Management of hepatocellular carcinoma: An update , 2011, Hepatology.

[20]  Kurinchi Gurusamy,et al.  Clinical outcomes of radiofrequency ablation, percutaneous alcohol and acetic acid injection for hepatocelullar carcinoma: a meta-analysis. , 2010, Journal of hepatology.

[21]  A. Villers,et al.  Vascular endocan (ESM‐1) is markedly overexpressed in clear cell renal cell carcinoma , 2010, Histopathology.

[22]  R. Huang,et al.  Epithelial-Mesenchymal Transitions in Development and Disease , 2009, Cell.

[23]  Stephanie Roessler,et al.  MicroRNA expression, survival, and response to interferon in liver cancer. , 2009, The New England journal of medicine.

[24]  Yi Tie,et al.  miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells. , 2009, Cancer letters.

[25]  Thomas D. Schmittgen,et al.  Regulation of microRNA processing in development, differentiation and cancer , 2008, Journal of cellular and molecular medicine.

[26]  G. Goodall,et al.  The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1 , 2008, Nature Cell Biology.

[27]  Kou-Juey Wu,et al.  Direct regulation of TWIST by HIF-1α promotes metastasis , 2008, Nature Cell Biology.

[28]  Xueli Yuan,et al.  Endothelial-to-mesenchymal transition contributes to cardiac fibrosis , 2007, Nature Medicine.

[29]  Karl T Kelsey,et al.  MicroRNA responses to cellular stress. , 2006, Cancer research.

[30]  C. Croce,et al.  MicroRNA signatures in human cancers , 2006, Nature Reviews Cancer.

[31]  H. Horvitz,et al.  MicroRNA expression profiles classify human cancers , 2005, Nature.

[32]  C. McCulloch,et al.  Integrity of cell-cell contacts is a critical regulator of TGF-beta 1-induced epithelial-to-myofibroblast transition: role for beta-catenin. , 2004, The American journal of pathology.

[33]  G. Mansueto,et al.  A case of rapid intrahepatic dissemination of hepatocellular carcinoma after radiofrequency thermal ablation. , 2004, American journal of surgery.

[34]  G. Tiberio,et al.  Aggressive recurrence after radiofrequency ablation of liver neoplasms. , 2003, Hepato-gastroenterology.

[35]  N. Ohkohchi,et al.  Rapid and aggressive recurrence accompanied by portal tumor thrombus after radiofrequency ablation for hepatocellular carcinoma , 2003, International Journal of Clinical Oncology.

[36]  J. Tavernier,et al.  ESM-1 Is a Novel Human Endothelial Cell-specific Molecule Expressed in Lung and Regulated by Cytokines* , 1996, The Journal of Biological Chemistry.

[37]  S. Kaneko,et al.  Radiofrequency ablation induces dedifferentiation of hepatocellular carcinoma. , 2010, Oncology letters.

[38]  G. Calin,et al.  MicroRNA identification in plasma and serum: a new tool to diagnose and monitor diseases. , 2009, Expert opinion on biological therapy.

[39]  William P Schiemann,et al.  Role of transforming growth factor-beta in cancer progression. , 2006, Future oncology.

[40]  C. McCulloch,et al.  Integrity of cell-cell contacts is a critical regulator of TGF-beta 1-induced epithelial-to-myofibroblast transition: role for beta-catenin. , 2004, The American journal of pathology.